Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone with N-acetylcysteine in Drug Induced Liver Injury
NCT02686385Terminated
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2016
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone in drug induced liver injury (DILI) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Proportion of patients with normalization of Liver Function Test at 20 days. Started Mar 2016; status: terminated.
02
Drugs
prednisolone
03
Conditions
drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT02686385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686385.